Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Obstet Gynecol. Nov 10, 2013; 2(4): 80-86
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.80
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.80
Individualized misoprostol dosing for labor induction or augmentation: A review
Shi-Yann Cheng, Department of Obstetrics and Gynecology, China Medical University Beigang Hospital, Yunlin County 65152, Taiwan
Author contributions: Cheng SY solely contributed to this paper.
Correspondence to: Shi-Yann Cheng, MD, Department of Obstetrics and Gynecology, China Medical University Beigang Hospital, 123 Shinder Road, Beigang Town, Yunlin County 65152, Taiwan. shiyann.cheng@msa.hinet.net
Telephone: +886-5-7837933 Fax: +886-5-7836439
Received: March 18, 2013
Revised: June 3, 2013
Accepted: July 18, 2013
Published online: November 10, 2013
Processing time: 245 Days and 0.3 Hours
Revised: June 3, 2013
Accepted: July 18, 2013
Published online: November 10, 2013
Processing time: 245 Days and 0.3 Hours
Core Tip
Core tip: Avoiding uterine tachysystole and fetal hypoxia is the critical consideration when implementing labor induction or augmentation with misoprostol. Titrated oral misoprostol is potentially an ideal alternative to traditional dinoprostone, oxytocin or the previously established misoprostol dosing method for labor induction or augmentation.